FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage

Shortages of cisplatin and carboplatin, bedrock cancer treatments, have forced some hospitals to ration the drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.